Try our Advanced Search for more refined results
Searching dockets in Opiant Pharmaceuticals Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Securities/Commodities | New York Southern
Notice of Voluntary Dismissal
NOTICE OF VOLUNTARY DISMISSAL pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, against the defendant(s) Craig Collard, Roger Crystal, MD, Richard J. Daly, Ann J.D. MacDougall, Lorianne Masuoka, MD, Opiant Pharmaceuticals, Inc., Gabrielle A. Silver, MD, Michael Sinclair, MD, Thomas T. Thomas. Document filed by Ryan O'Dell. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers)...(Melwani, Gloria)
NOTICE OF VOLUNTARY DISMISSAL pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, and without costs against the defendant(s) Craig Collard, Roger Crystal, Richard J. Daly, Ann MacDougall, Lorianne Masuoka, Opiant Pharmaceuticals, Inc., Gabrielle A. Silver, Michael Sinclair, Thomas T. Thomas. Document filed by Brian Jones. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers)...(Acocelli, Richard)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.